These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2940855)

  • 21. Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
    Nanas JN; Tsagalou EP; Nanas SN; Terrovitis JV; Tsolakis EJ; Toumanidis S; Papazoglou PD; Alexopoulos GP; Kanakakis J; Anastasiou-Nana MI
    Int J Cardiol; 2006 Apr; 108(2):237-43. PubMed ID: 16183152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic correlates of left ventricular versus right ventricular radionuclide volumetric responses to vasodilator therapy in congestive heart failure secondary to ischemic or dilated cardiomyopathy.
    Konstam MA; Weiland DS; Conlon TP; Martin TT; Cohen SR; Eichhorn EJ; Isner JM; Zile MR; Salem DN
    Am J Cardiol; 1987 May; 59(12):1131-7. PubMed ID: 3578055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arterial hemodynamics and cardiac effects of enoximone, dobutamine, and their combination in severe heart failure.
    Thuillez C; Richard C; Teboul JL; Annane D; Bellissant E; Auzepy P; Giudicelli JF
    Am Heart J; 1993 Mar; 125(3):799-808. PubMed ID: 8438709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined hemodynamic and scintigraphic assessment of piroximone (MDL 19,205) and comparison with dobutamine and nitroprusside.
    Massie BM; Cornyn J; Topic N; Loge D; Podolin RA
    Am J Cardiol; 1987 Sep; 60(8):647-53. PubMed ID: 3661429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy.
    Heiss HW; Hasenfuss G; Holubarsch C; Meinertz T; Just H
    Am J Cardiol; 1987 Aug; 60(5):53C-56C. PubMed ID: 2956869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemodynamic effects of enoximone and comparison with dobutamine in patients with chronic respiratory insufficiency and pulmonary arterial hypertension].
    Coulaud JM; Faitg R; Poler F; Rezgui N; Besse B; Lissac J
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():51-6. PubMed ID: 2147835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Enoximone in postoperative "low-output syndrome"--comparison with dobutamine].
    Orellano L; Darwisch M; Dieterich HA; Köllner V
    Z Kardiol; 1991; 80 Suppl 4():53-7. PubMed ID: 1833898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute hemodynamic response to low dose enoximone (MDL 17,043): an oral dose-range study.
    Gilbert EM; Bristow MR; Mason JW
    Am J Cardiol; 1987 Aug; 60(5):57C-62C. PubMed ID: 2956870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic effects of MDL 17,043, a new cardiotonic agent, in patients with congestive heart failure: comparison with sodium nitroprusside.
    Arbogast R; Brandt C; Haegele KD; Fincker JL; Schechter PJ
    J Cardiovasc Pharmacol; 1983; 5(6):998-1004. PubMed ID: 6196573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
    Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Spangenberg RB; Follansbee WP
    Circulation; 1983 Apr; 67(4):823-8. PubMed ID: 6218939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inotropic effect of enoximone in patients with severe heart failure: demonstration by left ventricular end-systolic pressure-volume analysis.
    Herrmann HC; Ruddy TD; William G; Strauss HW; Boucher CA; Fifer MA
    J Am Coll Cardiol; 1987 May; 9(5):1117-23. PubMed ID: 2952702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias.
    Miles WM; Heger JJ; Minardo JD; Klein LS; Prystowsky EN; Zipes DP
    Am Heart J; 1989 Jan; 117(1):112-21. PubMed ID: 2521415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
    Richard C; Thuillez C; Annane D; Bellissant E; Teboul JL
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():33-7. PubMed ID: 2147832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of enoximone versus tobutamine in the treatment of low cardiac output after cardiac surgery].
    Lançon JP; Caillard B; Volot F; Obadia JF; Bock F
    Ann Fr Anesth Reanim; 1990; 9(3):289-94. PubMed ID: 2142589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic and hemodynamic effects of combined beta-agonist stimulation and phosphodiesterase inhibition in the failing human heart.
    Gilbert EM; Hershberger RE; Wiechmann RJ; Movsesian MA; Bristow MR
    Chest; 1995 Dec; 108(6):1524-32. PubMed ID: 7497755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failure.
    Amin DK; Shah PK; Hulse S; Shellock FG; Swan HJ
    Am Heart J; 1984 Nov; 108(5):1285-92. PubMed ID: 6238513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saterinone, dobutamine, and sodium nitroprusside: comparison of cardiovascular profiles in patients with congestive heart failure.
    Kieback AG; Iven H; Stolzenburg K; Baumann G
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):629-36. PubMed ID: 9781932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response.
    Uretsky BF; Generalovich T; Verbalis JG; Valdes AM; Reddy PS
    J Am Coll Cardiol; 1985 Jun; 5(6):1414-21. PubMed ID: 3158689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.